Clinical Study

DROPLET-BC study is a prospective clinical trial based in the U.S. to evaluate the performance of our PREMIR blood test for early detection of breast cancer

Study Details

DROPLET-BC; The Detection by circulating RNA with OPtimized machine LEarning Technology for Breast Cancer

The goal of DROPLET-BC is to classify breast cancer patients from non-cancer volunteers by assessing the profile of circulating small-noncoding RNA in the blood with statistical validation. 1,200 individuals are expected to be enrolled. Information from this study will be utilized to develop a new method of breast cancer screening.

Further information at

Interested in Collaborating? 
Contact Us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We use cookies to provide you with a greater online experience. By using our sites, you agree to our use of cookies. See our cookie policy.